gene synthesis
Camena Bioscience Closes $10M Series A Financing Round
The UK-based synthetic biology startup said it will use the funding to scale its operations and to further develop its gSynth enzymatic DNA synthesis platform.
Ansa Biotechnologies Accelerating Enzymatic DNA Synthesis Technology as a Commercial Service
Premium
The University of California, Berkeley spinout hopes to stand out in the synthetic DNA race using its polymerase-nucleotide conjugation approach.
Ansa Biotechnologies Closes $68M Series A Financing
The University of California, Berkeley spinout plans to use the funding to accelerate development of its enzymatic DNA synthesis technology.
Molecular Assemblies Extends Series A Financing Round by $11.8M
The enzymatic DNA synthesis company added money from new and existing investors to a 2019 $12.2 million Series A round led by iSelect Fund.
Piper Sandler Initiates Coverage of Twist Bioscience, Codexis With Overweight Ratings
The investment bank said it believes Twist's high growth is "sustainable" and that synthetic biology is the most exciting market in the life sciences sector.
Mar 18, 2021
Feb 5, 2021
Dec 2, 2020
Twist Bioscience Proposes $250M Public Offering
Nov 23, 2020
Nov 23, 2020
Twist Bioscience Fiscal Q4 Revenues More Than Double
Aug 6, 2020
Twist Bioscience Q3 Revenues Grow 56 Percent
Jun 4, 2020
Twist Bioscience Prices $100M Stock Offering
May 21, 2020
May 7, 2020
Twist Bioscience Q2 Revenues Increase 42 Percent
Mar 2, 2020
Evonetix Closes £23M Series B Financing
Dec 12, 2019